CHONG KUN DANG Trademark

Trademark Overview


On Wednesday, June 12, 2019, a trademark application was filed for CHONG KUN DANG with the United States Patent and Trademark Office. The USPTO has given the CHONG KUN DANG trademark a serial number of 88470347. The federal status of this trademark filing is REGISTERED as of Tuesday, October 6, 2020. This trademark is owned by CHONG KUN DANG HOLDINGS CORP.. The CHONG KUN DANG trademark is filed in the Pharmaceutical Products category with the following description:

Vitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations, namely, antivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the...
chong kun dang

General Information


Serial Number88470347
Word MarkCHONG KUN DANG
Filing DateWednesday, June 12, 2019
Status700 - REGISTERED
Status DateTuesday, October 6, 2020
Registration Number6166899
Registration DateTuesday, October 6, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Goods and ServicesVitamin preparations; Antibiotic preparations; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating respiratory diseases; Allergy medications; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Cardiovascular agents for medical purposes; Amino acids for medical purposes; Dermatological pharmaceutical preparations; Ophthalmic preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations, namely, antivirals; Tumor suppressing agents; Pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of hyperlipidemia; Anti-inflammatories; Analgesics; Bacterial poisons; Pharmaceutical preparations for the treatment of cellular disorders; Pharmaceutical preparations for the treatment of bone diseases; Pharmaceutical preparations for use in urology; Vaccines; Nutritional supplements, namely, tonics and alternatives for medical purposes; Antibiotics; pharmaceutical preparation for the arthritis treatment; pharmaceutical preparation for the rheumarthritis treatment; Anti-cancer preparations; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of cancer; Health food supplement mainly based on lactic acid bacteria; Nutritional supplements, namely, probiotic compositions; Lactic acid bacteria in the form of capsules for medical purpose; Lactose for medical purposes; Powdered milk for babies; Calcium supplements; Powdered nutritional supplement drink mixes; Probiotic supplements; Pharmaceutical preparations for use in the treatment of diabetes, anemia, cardiovascular disease, weight loss, hormone replacement, nutritional deficiencies, infectious disease, autoimmune disease, fatigue, inflammation, pain, environmental toxicities, and heavy metal toxicities; Nutraceutical preparations for therapeutic or medical purposes in the treatment of gout; nutraceuticals for use as a dietary supplement; Anti-oxidant food supplements; Food supplements, namely, anti-oxidants; Food supplements; Dietary supplements; Medicated food supplements
Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCHONG KUN DANG HOLDINGS CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeoul 120-756
KR

Party NameCHONG KUN DANG HOLDINGS CORP.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 120-756
KR

Party NameCHONG KUN DANG HOLDINGS CORP.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 120-756
KR

Trademark Events


Event DateEvent Description
Tuesday, October 6, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 2, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 10, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 1, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, April 1, 2020LETTER OF SUSPENSION E-MAILED
Wednesday, April 1, 2020SUSPENSION LETTER WRITTEN
Wednesday, March 11, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 9, 2020ASSIGNED TO LIE
Tuesday, March 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 5, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 5, 2019NON-FINAL ACTION E-MAILED
Thursday, September 5, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2019ASSIGNED TO EXAMINER
Tuesday, June 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 15, 2019NEW APPLICATION ENTERED IN TRAM